Emerging monkeypox cases amid the ongoing COVID-19 pandemic in the Indian subcontinent: A probable healthcare challenge for South East Asia
Front Public Health
.
2022 Nov 25:10:1066425.
doi: 10.3389/fpubh.2022.1066425.
eCollection 2022.
Authors
Ranjan K Mohapatra
1
,
Snehasish Mishra
2
,
Venkataramana Kandi
3
,
Ashish K Sarangi
4
,
Md Kudrat-E-Zahan
5
,
Md Sajid Ali
6
,
Rudra Narayan Sahoo
7
,
Nawazish Alam
8
,
Gurudutta Pattnaik
7
,
Kuldeep Dhama
9
Affiliations
1
Department of Chemistry, Government College of Engineering, Keonjhar, Odisha, India.
2
School of Biotechnology, KIIT Deemed to be University, Bhubaneswar, Odisha, India.
3
Department of Microbiology, Prathima Institute of Medical Sciences, Karimnagar, Telangana, India.
4
Department of Chemistry, School of Applied Sciences, Centurion University of Technology and Management, Bhubaneswar, Odisha, India.
5
Department of Chemistry, Rajshahi University, Rajshahi, Bangladesh.
6
Department of Pharmaceutics, College of Pharmacy, Jazan University, Jazan, Saudi Arabia.
7
School of Pharmacy and Life Sciences, Centurion University of Technology and Management, Bhubaneswar, Odisha, India.
8
Department of Pharmacy Practice, College of Pharmacy, Jazan University, Jazan, Saudi Arabia.
9
Division of Pathology, ICAR-Indian Veterinary Research Institute, Bareilly, Uttar Pradesh, India.
PMID:
36504935
PMCID:
PMC9732369
DOI:
10.3389/fpubh.2022.1066425
No abstract available
Keywords:
South East Asia; monkeypox disease; prevention and control; public health; treatment.
MeSH terms
COVID-19* / epidemiology
Delivery of Health Care
Humans
Longitudinal Studies
Mpox, Monkeypox
Pandemics*
Probability